Investment beckons in health care in China
Print Edition
CHINESE demand for better health care quality and structural reform of the sector will offer abundant investment opportunities, a conference in Shanghai heard yesterday.
By 2020, China’s health care market is estimated to grow at a compound annual rate of as much as 20 percent, Richard Yeh, head of China Healthcare Research at Citi Research, told the China Healthcare Investment Conference yesterday.
Zhu Hongren, former chief engineer at the Ministry of Industry and Information Technology, said in a keynote speech that the country’s aging population as well as investors’ enthusiasm for the health care sector are providing new growth potential under China’s new economic scenario.
Norman Chen, venture partner at Fidelity Growth Partners Asia, said he’s seeing a large number of investment opportunities across different sectors including biopharmaceuticals, medical devices and retail.
Lu Hongbo, managing director of OrbiMed, a health care investment firm which oversees US$14 billion of assets globally, said investment will rise in emerging countries in Asia.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
